173
Participants
Start Date
December 1, 2021
Primary Completion Date
July 26, 2024
Study Completion Date
February 18, 2025
Sotatercept
SC injection
Placebo
Placebo-matched SC injection
La Sapienza-Università di Roma-Policlinico Umberto I ( Site 2402), Roma
Hôpital Erasme ( Site 1402), Anderlecht
St Vincent's Hospital Sydney ( Site 1102), Darlinghurst
John Hunter Hospital ( Site 1101), New Lambton Heights
UZ Leuven Campus Gasthuisberg ( Site 1401), Leuven
Instituto Nacional De Cardiologia Dr. Ignacio Chavez ( Site 2503), Mexico City
The George Washington University Medical Faculty Associates ( Site 1025), Washington D.C.
Ospedale S. Giuseppe Multimedica ( Site 2403), Milan
Duke University Medical Center ( Site 1026), Durham
Hospital Universitario 12 de Octubre ( Site 1603), Madrid
Medical University of South Carolina - PPDS ( Site 1003), Charleston
Northside Hospital ( Site 1073), Atlanta
Medizinische Hochschule Hannover ( Site 1505), Hanover
Centre Hospitalier Universitaire de Toulouse. ( Site 1315), Toulouse
Mayo Clinic Jacksonville - PPDS ( Site 1045), Jacksonville
AdventHealth Medical Group Advanced Lung Disease ( Site 1058), Orlando
Lady Davis Carmel Medical Center ( Site 1705), Haifa
Universitaetsklinikum Giessen und Marburg GmbH ( Site 1512), Giessen
Statcare Pulmonary Consultants - Knoxville ( Site 1031), Knoxville
University of Michigan ( Site 1011), Ann Arbor
Uniklinik Köln ( Site 1511), Cologne
University Of Iowa Hospitals and Clinics ( Site 1050), Iowa City
Medical College of Wisconsin - Froedtert Hospital ( Site 1051), Milwaukee
CHU de Nancy - Hôpital de Brabois Adultes ( Site 1308), Vandœuvre-lès-Nancy
CHRU Lille ( Site 1306), Lille
Washington University School of Medicine ( Site 1022), St Louis
"Hospital Universitario Dr. Jose Eleuterio Gonzalez ( Site 2504)", Monterrey
Unidad de Investigación Clínica en Medicina, S.C ( Site 2505), Monterrey
University of Kansas Medical Center ( Site 1020), Kansas City
Universitätsklinikum des Saarlandes ( Site 1513), Homburg
Hôpitaux Universitaires de Strasbourg ( Site 1307), Strasbourg
University of Nebraska Medical Center ( Site 1053), Omaha
Thoraxklinik-Heidelberg gGmbH ( Site 1509), Heidelberg
Hôpital Louis Pradel ( Site 1317), Bron
University Of Texas Southwestern Medical Center ( Site 1038), Dallas
University of Colorado Hospital ( Site 1013), Aurora
Krankenhaus Neuwittelsbach ( Site 1510), München
Arizona Pulmonary Specialists ( Site 1010), Phoenix
CHU de Poitiers ( Site 1316), Poitiers
University of New Mexico Health Sciences Center ( Site 1048), Albuquerque
David Geffen School of Medicine at UCLA ( Site 1068), Los Angeles
University of California San Diego Medical Center ( Site 1002), San Diego
University of California San Francisco ( Site 1019), San Francisco
CHU Bicêtre ( Site 1304), Le Kremlin-Bicêtre
University of California Irvine ( Site 1086), Orange
Tufts Medical Center - PPDS ( Site 1012), Boston
Brigham and Women's Hospital ( Site 1014), Boston
University of Rochester Medical Center - PPDS ( Site 1039), Rochester
University of Cincinnati Medical Center ( Site 1035), Cincinnati
The Cleveland Clinic Foundation. ( Site 1065), Cleveland
Peter Lougheed Centre ( Site 2102), Calgary
Jewish General Hospital ( Site 2103), Montreal
Universitätsklinikum Carl Gustav Carus an der TU Dresden. ( Site 1501), Dresden
VU Medisch Centrum ( Site 2601), Amsterdam
Royal Papworth Hospital ( Site 1208), Cambridge
Royal Brompton Hospital ( Site 1206), London
Imperial College Healthcare NHS Trust ( Site 1203), London
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
INDUSTRY